Viking Therapeutics (VKTX) Q3 2022 Earnings

26OctConfirmed
Feb 22
Apr 22
Jul 22
Q3 2022
-0.23
-0.21
-0.18
-0.16

Details

Expected EPS
-0.23
Actual EPS
-0.21
Surprise EPS
0.02
Surprise Percent
+8.7%

Description

Viking Therapeutics (VKTX) has reported earnings of -0.21 per share for Q3 2022.

0 Comments

Share your thoughts